Maria Luisa Biondi

About Diatech Pharmacogenetics

This author has not yet filled in any details.
So far Diatech Pharmacogenetics has created 1081 blog entries.

1 05, 2015

Chiara Colato et al., Break–apart interphase fluorescence in situ hybridization assay in papillary thyroid carcinoma: on the road to optimizing the cut-off level for RET/PTC rearrangements. European Journal of Endocrinology

Diatech Pharmacogenetics2015-05-01T11:47:22+02:00

6 04, 2015

Mariani S, Di Bello C, Bonello L, Tondat F, Pacchioni D, Molinaro L, et al. (2015) Flexible Lab-Tailored Cut-Offs for Suitability of Formalin-Fixed Tumor Samples for Diagnostic Mutational Analyses. PLoS ONE 10(4): e0121815.

Diatech Pharmacogenetics2015-04-06T13:41:39+02:00

6 04, 2015

Daniela Massi et al., Immunohistochemistry is highly sensitive and specific for the detection of NRASQ61R mutation in melanoma. Modern Pathology

Diatech Pharmacogenetics2015-04-06T12:11:18+02:00

1 04, 2015

Giovanna De Maglio et al., MGMT promoter methylation status in brain metastases from colorectal cancer and corresponding primary tumors. Future Oncology

Diatech Pharmacogenetics2015-04-01T15:10:08+02:00

1 04, 2015

Giulia Cini et al., Concomitant mutation and epimutation of the MLH1 gene in a Lynch syndrome family. Carcinogenesis

Diatech Pharmacogenetics2017-08-08T12:23:51+02:00

27 03, 2015

Diatech Pharmacogenetics obtained by the European Union a founding of Euro 2 million in Horizon 2020
Diatech Pharmacogenetics obtained by the European Union a founding of Euro 2 million in Horizon 2020

News

Diatech Pharmacogenetics obtained by the European Union a founding of Euro 2 million in Horizon 2020

Diatech Pharmacogenetics2017-09-08T17:16:57+02:00

27 03, 2015

Da Horizon 2020 1,7 milioni a DIatech per i test anti-cancro

Diatech Pharmacogenetics2022-04-19T16:29:10+02:00

9 03, 2015

Elisa Chiadiniet al., EGFR methylation and outcome of patients with advanced colorectal cancer treated with cetuximab. Oncology Letters

Diatech Pharmacogenetics2015-03-09T14:03:41+01:00

4 03, 2015

Il Gruppo Diatech partecipa a NGS 2015

Diatech Pharmacogenetics2022-04-19T16:39:04+02:00

1 02, 2015

Luisa Foltran et al., Prognostic role of KRAS, NRAS, BRAF and PIK3CA mutations in advanced colorectal cancer. Future Oncology

Diatech Pharmacogenetics2015-02-01T15:15:55+01:00

Previous 282930 Next